Conclusions
PC is rare and challenging to recognize skin cancer with a high risk of
recurrence and metastasis. Despite its rarity, eccrine PC is the most
common sweat gland. The differential diagnosis for every suspicious
cutaneous lesion is needed to prevent delays in treatment.
Our clinical case suggests that early identification and complete
excision offer the best chances of feasible recovery even in elderly
patients in poor general condition and with numerous comorbidities.
No treatment has been standardized yet. Surgery is the first and only
therapeutic option that could significantly affect patient outcomes.
Chemotherapy and radiotherapy have not shown clinical benefits in the
management of advanced PC.
Due to its rarity, further research, including case reports, is
necessary to improve the diagnosis and therapy of PC.